Cardiac Rhythm Management Market Revenue and Value Chain 2015-2025

Around 30% of total death worldwide is caused by cardiovascular diseases, of which major part is accounted by heart diseases. The risk factors of heart disease includes elevated cholesterol levels, diabetes mellitus, cigarette smoking, obesity and hypertension. Frequency of these factors varies demographically, i.e. on the basis of geography, sex ratio and ethnicity.Ischaemic heart disease, is the leading type of heart disease, and causes 46% of cardiovascular deaths in men and 38% in women.

Cardiac rhythm management market is the established segment of cardiology devices market, used majorly in the treatment of patients suffering from congestive heart failure (CHF) and atrial fibrillation (AF).

Request Free Report Sample @

Cardiac Rhythm Management Market: Drivers & Restraints        

An implantable cardioverter-defibrillator (ICD) is a specialized device designed to directly treat a cardiac tachydysrhythmia. High level of alcohol consumption, cholesterol levels and smoking obesity contribute to heart disease; continence of such lifestyle will increase the requirement of ICD implants. Lack of awareness about sudden cardiac arrests and high cost of the devices is expect to hinder the growth of the cardiac rhythm management market. Higher disposable income increase in number of aging population, technological advancement will spur the growth of global cardiac rhythm management market.

Cardiac Rhythm Management Market: Segmentation

On the basis of devices, cardiac rhythm management market is broadly segmented as:

Cardiac Rhythm Pacemakers

Single Chamber Pacemakers

Dual Chamber Pacemakers

Cardiac Resynchronization Therapy

Cardiac Resynchronization Therapy – Pacemakers

Cardiac Resynchronization Therapy – Defibrillators

Implantable Cardioverter Defibrillators

Transvenous implantable cardioverter defibrillators (T-ICDs)

Subcutaneous implantable cardioverter...